Skip to main content

Table 4 Predicted 5- and 10-year biochemical free survival (BFS) for salvage radiotherapy (sRT) after radical prostatectomy based on the updated Stephenson nomogram

From: Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial

  

Therapeutic decision

  
  

sRT alone (%)

ADT ± sRT (%)

Mean Difference (95% CI)

P-value1

Pre-molecular imaging

5-year BFS probability

50.91

46.13

4.79 (-4.63;14.20)

0.3141

10-year BFS probability

38.16

33.56

4.60 (-4.99;14.18)

0.3423

Post-molecular imaging

5-year BFS probability

52.5

43.3

9.2 (0.78;17.56)

0.0327*

10-year BFS probability

39.94

30.24

9.70 (1.93;18.22)

0.0260*

  1. Based on two-sample Student’s t-Tests * < 0.05